{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8070427", "DateCompleted": {"Year": "1994", "Month": "09", "Day": "29"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "10"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0889-8529", "JournalIssue": {"Volume": "23", "Issue": "2", "PubDate": {"Year": "1994", "Month": "Jun"}}, "Title": "Endocrinology and metabolism clinics of North America", "ISOAbbreviation": "Endocrinol Metab Clin North Am"}, "ArticleTitle": "Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess.", "Pagination": {"StartPage": "359", "EndPage": "377", "MedlinePgn": "359-77"}, "Abstract": {"AbstractText": ["Excessive ingestion of licorice induces a syndrome of hypokalemia and hypertension that reflects increased activation of renal mineralocorticoid receptors by cortisol. A similar syndrome of cortisol-dependent mineralocorticoid excess occurs in congenital deficiency of the enzyme 11 beta-hydroxysteroid dehydrogenase, which normally inactivates cortisol to cortisone. It has been shown that licorice inhibits 11 beta-dehydrogenase, preventing local inactivation of cortisol and allowing cortisol inappropriate access to intrinsically nonspecific renal mineralocorticoid receptors. Further studies with licorice and its derivatives have revealed a widespread role for 11 beta-dehydrogenase in regulating tissue sensitivity to cortisol. Deficient 11 beta-dehydrogenase activity provides a novel pathogenetic mechanism for hypertension, and current research suggests that several common forms of hypertension can be explained by the mechanisms that operate in licorice-induced hypertension."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Edinburgh, Western General Hospital, Scotland, United Kingdom."}], "LastName": "Walker", "ForeName": "B R", "Initials": "BR"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Edwards", "ForeName": "C R", "Initials": "CR"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Endocrinol Metab Clin North Am", "NlmUniqueID": "8800104", "ISSNLinking": "0889-8529"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Mineralocorticoids"}, {"RegistryNumber": "MM6384NG73", "NameOfSubstance": "Carbenoxolone"}, {"RegistryNumber": "P540XA09DR", "NameOfSubstance": "Glycyrrhetinic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adrenal Hyperplasia, Congenital"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Carbenoxolone"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Glycyrrhetinic Acid"}, {"QualifierName": ["chemistry"], "DescriptorName": "Glycyrrhiza"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["etiology"], "DescriptorName": "Hyperaldosteronism"}, {"QualifierName": ["etiology"], "DescriptorName": "Hypertension"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Mineralocorticoids"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}], "NumberOfReferences": "93"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1994", "Month": "6", "Day": "1"}, {"Year": "1994", "Month": "6", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1994", "Month": "6", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8070427"]}}]}